GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common antiviral drug extend life in brain cancer?
Disease control OngoingThis phase 2 study tests whether adding the antiviral drug valganciclovir to standard treatment can help people with glioblastoma, an aggressive brain cancer. The drug targets cytomegalovirus (CMV), which is often found in these tumors and may make them more aggressive. About 220…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE2 • Sponsor: Cecilia Soderberg-Naucler • Aim: Disease control
Last updated Apr 29, 2026 00:21 UTC
-
Engineered immune cells take on deadly brain cancer
Disease control OngoingThis early-phase study tests a new treatment for glioblastoma, a fast-growing brain tumor. The therapy uses a patient's own immune cells, modified to target a protein called CD70 on tumor cells and to better reach the brain. The main goals are to see if the treatment is safe and …
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Apr 29, 2026 00:20 UTC
-
Virus therapy takes on brain cancer: early trial underway
Disease control OngoingThis early-phase study tests a modified herpes virus designed to attack brain tumor cells directly. The virus is injected into the tumor, and some participants also receive a drug to boost the immune response. The main goal is to find the safest dose and see how the body reacts. …
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 29, 2026 00:19 UTC
-
Vitamin c and iron combo takes on brain tumors in first human test
Disease control OngoingThis early-phase study tests whether adding high-dose vitamin C and an iron-based drug (ferumoxytol) to standard radiation and chemotherapy can help control glioblastoma, an aggressive brain tumor. About 17 adults with newly diagnosed glioblastoma will receive these added treatme…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Bryan Allen • Aim: Disease control
Last updated Apr 28, 2026 13:06 UTC